{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:21:15Z","timestamp":1791472875294,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022777","name":"Cyteir Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022777","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ymthe.2023.05.009","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T04:08:15Z","timestamp":1684210095000},"page":"2132-2153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chimeric TIM-4 receptor-modified T\u00a0cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T\u00a0cell cross-presentation"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3268-7444","authenticated-orcid":false,"given":"Brandon","family":"Cieniewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Bhatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damoun","family":"Torabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Baichoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Saxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Arballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Kethar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phanidhar","family":"Kukutla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omolola","family":"Shoaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiu","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4347-4646","authenticated-orcid":false,"given":"Daniel","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.05.009_bib1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T\u00a0cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2023.05.009_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T\u00a0cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2017.02.008","article-title":"Obstacles posed by the tumor microenvironment to T\u00a0cell activity: a case for synergistic therapies","volume":"31","author":"Anderson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2023.05.009_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","article-title":"Tumor-specific T\u00a0cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis","volume":"45","author":"Schietinger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.05.009_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2023.05.009_bib6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2023.05.009_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2023.05.009_bib8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib9","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41467-019-11911-5","article-title":"Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.05.009_bib10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2023.05.009_bib11","doi-asserted-by":"crossref","first-page":"e001408","DOI":"10.1136\/jitc-2020-001408","article-title":"Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review","volume":"8","author":"Lecoultre","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2023.05.009_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2008.09.004","article-title":"Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis","volume":"14","author":"De Palma","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2023.05.009_bib13","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.cell.2021.02.048","article-title":"Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis","volume":"184","author":"Kaczanowska","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.05.009_bib14","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1807315","article-title":"CD47 blockade by Hu5F9-G4 and rituximab in non-hodgkin's lymphoma","volume":"379","author":"Advani","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.05.009_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1158\/1078-0432.CCR-21-2160","article-title":"First-in-Class anti-immunoglobulin-like transcript 4 myeloid-specific antibody MK-4830 abrogates a PD-1 resistance mechanism in patients with advanced solid tumors","volume":"28","author":"Siu","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2023.05.009_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2528","article-title":"Trophic macrophages in development and disease","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.05.009_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2023.05.009_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.05.009_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","article-title":"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells","volume":"595","author":"Casanova-Acebes","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.05.009_bib21","doi-asserted-by":"crossref","first-page":"eaat1500","DOI":"10.1126\/scitranslmed.aat1500","article-title":"Human tumor-associated monocytes\/macrophages and their regulation of T\u00a0cell responses in early-stage lung cancer","volume":"11","author":"Singhal","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.05.009_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41587-020-0520-5","article-title":"Cancer-eating immune cells kitted out with CARs","volume":"38","author":"Dolgin","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib23","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.4049\/jimmunol.0901772","article-title":"Human gamma delta T\u00a0cells: a lymphoid lineage cell capable of professional phagocytosis","volume":"183","author":"Wu","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib24","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1172\/JCI34487","article-title":"Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells","volume":"118","author":"Ichimura","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.05.009_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fimmu.2018.00044","article-title":"Clearance of apoptotic cells by tissue epithelia: a putative role for hepatocytes in liver efferocytosis","volume":"9","author":"Davies","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.imbio.2015.12.003","article-title":"Human B cells have an active phagocytic capability and undergo immune activation upon phagocytosis of Mycobacterium tuberculosis","volume":"221","author":"Zhu","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.ymthe.2023.05.009_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.immuni.2011.06.003","article-title":"T cell receptor internalization from the immunological synapse is mediated by TC21 and RhoG GTPase-dependent phagocytosis","volume":"35","author":"Mart\u00ednez-Mart\u00edn","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.05.009_bib28","author":"Kadin"},{"key":"10.1016\/j.ymthe.2023.05.009_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12964-021-00766-3","article-title":"Mechanisms and functions of endocytosis in T\u00a0cells","volume":"19","author":"Charpentier","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ymthe.2023.05.009_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.immuni.2007.11.011","article-title":"TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells","volume":"27","author":"Kobayashi","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.05.009_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1128\/MCB.05993-11","article-title":"Two-step engulfment of apoptotic cells","volume":"32","author":"Toda","year":"2012","journal-title":"Mol. Cel. Biol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature06307","article-title":"Identification of Tim4 as a phosphatidylserine receptor","volume":"450","author":"Miyanishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.05.009_bib33","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/s41467-021-22535-z","article-title":"TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses","volume":"12","author":"Caronni","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.05.009_bib34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cub.2009.01.042","article-title":"The phosphatidylserine receptor TIM-4 does not mediate direct signaling","volume":"19","author":"Park","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1084\/jem.20031237","article-title":"Toll-like receptors induce a phagocytic gene program through p38","volume":"199","author":"Doyle","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.05.009_bib36","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0360-3016(02)03928-7","article-title":"Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy","volume":"54","author":"Ran","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ymthe.2023.05.009_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2009.03.041","article-title":"Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner","volume":"283","author":"Lima","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2023.05.009_bib38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/334530a0","article-title":"T cells can present antigens such as HIV gp120 targeted to their own surface molecules","volume":"334","author":"Lanzavecchia","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.05.009_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/eji.1830240112","article-title":"Professional presentation of antigen by activated human T\u00a0cells","volume":"24","author":"Barnaba","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1091\/mbc.e13-04-0212","article-title":"The phosphatidylserine receptor TIM4 utilizes integrins as coreceptors to effect phagocytosis","volume":"25","author":"Flannagan","year":"2014","journal-title":"Mol. Biol. Cel"},{"key":"10.1016\/j.ymthe.2023.05.009_bib41","doi-asserted-by":"crossref","first-page":"836485","DOI":"10.1155\/2012\/836485","article-title":"The effects of TLR activation on T-cell development and differentiation","volume":"2012","author":"Jin","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1074\/jbc.275.1.141","article-title":"Rac1 and Cdc42 are required for phagocytosis, but not NF-kappaB-dependent gene expression, in macrophages challenged with Pseudomonas aeruginosa","volume":"275","author":"Lee","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2023.05.009_bib43","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1073\/pnas.1422576112","article-title":"Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain","volume":"112","author":"Mistry","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.05.009_bib44","first-page":"183","article-title":"Biogenesis of phagolysosomes: the 'kiss and run' hypothesis","volume":"5","author":"Desjardins","year":"1995","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.124.5.677","article-title":"Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus","volume":"124","author":"Desjardins","year":"1994","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2144\/btn-2020-0003","article-title":"Phagocytosis assays with different pH-sensitive fluorescent particles and various readouts","volume":"68","author":"Lindner","year":"2020","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymthe.2023.05.009_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/sgtp.19138","article-title":"RRas2, RhoG and T-cell phagocytosis","volume":"3","author":"Alarc\u00f3n","year":"2012","journal-title":"Small GTPases"},{"key":"10.1016\/j.ymthe.2023.05.009_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/tra.12233","article-title":"Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution","volume":"16","author":"Hankins","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.ymthe.2023.05.009_bib49","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41591-020-0757-z","article-title":"TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma","volume":"26","author":"Ennishi","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.05.009_bib50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/293302a0","article-title":"Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change","volume":"293","author":"Casella","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.05.009_bib51","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","article-title":"Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion","volume":"11","author":"Mauvezin","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2023.05.009_bib52","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1309\/AJCPAVFA8J3KHPRS","article-title":"Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V\/7-AAD assay: clinical relevance and comparison with other apoptosis parameters","volume":"132","author":"Dong","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib53","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.bbamem.2011.07.026","article-title":"In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy","volume":"1808","author":"Riedl","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2023.05.009_bib54","first-page":"3062","article-title":"Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes","volume":"51","author":"Utsugi","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2023.05.009_bib55","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1096\/fj.201800636R","article-title":"Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression","volume":"33","author":"Brehm","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2023.05.009_bib56","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1182\/blood-2009-08-232967","article-title":"Antibody-mediated B-cell depletion before adoptive immunotherapy with T\u00a0cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice","volume":"114","author":"James","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.05.009_bib57","doi-asserted-by":"crossref","first-page":"735","DOI":"10.21037\/atm.2019.12.03","article-title":"Preclinical safety evaluation of chimeric antigen receptor-modified T\u00a0cells against CD19 in NSG mice","volume":"7","author":"Wen","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.05.009_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.neo.7900209","article-title":"Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based pharmacokinetic model","volume":"4","author":"Melder","year":"2002","journal-title":"Neoplasia"},{"key":"10.1016\/j.ymthe.2023.05.009_bib59","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1084\/jem.20182375","article-title":"Single-cell imaging of CAR T\u00a0cell activity in\u00a0vivo reveals extensive functional and anatomical heterogeneity","volume":"216","author":"Cazaux","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.05.009_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fimmu.2019.00128","article-title":"CAR T\u00a0cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment","volume":"10","author":"Martinez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib61","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/bjc.2013.511","article-title":"EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice","volume":"109","author":"Gahr","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2023.05.009_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.05.009_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.05.009_bib64","doi-asserted-by":"crossref","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","article-title":"Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ettinger","year":"2022","journal-title":"J.\u00a0Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ymthe.2023.05.009_bib65","doi-asserted-by":"crossref","first-page":"e99488","DOI":"10.1172\/jci.insight.99488","article-title":"Engineered T\u00a0cells targeting E7 mediate regression of human papillomavirus cancers in a murine model","volume":"3","author":"Jin","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2023.05.009_bib66","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/S0140-6736(22)00662-6","volume":"399","author":"Kamdar","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2023.05.009_bib67","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2023.05.009_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2326-6066.CIR-13-0170","article-title":"Mesothelin-specific chimeric antigen receptor mRNA-engineered T\u00a0cells induce anti-tumor activity in solid malignancies","volume":"2","author":"Beatty","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2023.05.009_bib69","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"Bollard","year":"2014","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2023.05.009_bib70","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1056\/NEJMoa0800251","article-title":"Treatment of metastatic melanoma with autologous CD4+ T\u00a0cells against NY-ESO-1","volume":"358","author":"Hunder","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.05.009_bib71","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nprot.2009.22","article-title":"Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors","volume":"4","author":"Kutner","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2023.05.009_bib72","doi-asserted-by":"crossref","first-page":"106575","DOI":"10.1016\/j.prostaglandins.2021.106575","article-title":"Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells","volume":"156","author":"Xia","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623002642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623002642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:10:35Z","timestamp":1761502235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623002642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1525001623002642"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.05.009","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric TIM-4 receptor-modified T\u00a0cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T\u00a0cell cross-presentation","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}